Premium
Benefits of catch‐up in vaccination against human papillomavirus in medium‐ and low‐income countries
Author(s) -
Baussano Iacopo,
Lazzarato Fulvio,
Ronco Guglielmo,
Dillner Joakim,
Franceschi Silvia
Publication year - 2013
Publication title -
international journal of cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.475
H-Index - 234
eISSN - 1097-0215
pISSN - 0020-7136
DOI - 10.1002/ijc.28197
Subject(s) - vaccination , herd immunity , medicine , demography , cervical cancer , human papillomavirus , transmission (telecommunications) , cohort , herd , cervical screening , environmental health , immunology , cancer , veterinary medicine , sociology , electrical engineering , engineering
Human papillomavirus (HPV) vaccination of a birth cohort of girls in the 9–13 age range is recommended as a priority, but decreases in HPV vaccine cost may make catch‐up of a few additional cohorts more attractive not only in high‐income countries. We assessed the reduction in HPV16 and 18 infections that could be achieved in a medium‐ (Poland) and a low‐income (Guinea) country by adding one‐time catch‐up of 12‐ to 19‐year‐old girls to the vaccination of 11‐year‐old girls. According to our ad hoc adapted dynamic model of HPV infection transmission, the addition of catch‐up was estimated to bring forward the 50% reduction of HPV16/18 prevalence due to vaccination in women ≤35 by as much as 5 years. Catch‐up of 12‐ to 15‐year olds reduced the cumulative probability of HPV16/18 infections by age 35 in the relevant cohorts by about 30% in both countries. Catch‐up of 16‐ to 19‐year‐old girls added little. Regardless of the chosen catch‐up strategy, 16 to 20% of HPV16/18 prevention from vaccination was attributable to herd immunity. Assuming a sufficiently low vaccine cost, the addition of a catch‐up round is, therefore, worth considering in medium/low‐income countries to extend vaccine benefits to less young adolescent girls whose future access to cervical screening is uncertain.